Prognostic heterogeneity of endosonographic T3 rectal cancer

Diseases of the Colon and Rectum

Volumn 52, Issue 4, 2009, Pages 685-691

  Esclapez, Pedro ^a   Garcia Granero, Eduardo ^a   Flor, Blas ^a   García Botello, Stephanie ^a   Cervantes, Andres ^a   Navarro, Samuel ^a   Lledó, Salvador ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Endorectal ultrasonography; Preoperative staging; Rectal cancer; T3

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDORECTAL ULTRASONOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PROGNOSIS; RECTUM CANCER; RECTUM TUMOR; RECURRENCE RISK; CANCER INVASION; ECHOGRAPHY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; TUMOR RECURRENCE;

AGED; ENDOSONOGRAPHY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECTAL NEOPLASMS;

EID: 66849089241     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e31819ed03d     Document Type: Article

References (39)

1. Nicholls RJ. Surgery for rectal carcinoma. In: Nicholls RJ, Dozois RR, eds. Surgery of the colon and rectum. New York: Churchill Livingstone, 1997:427Y73.
2. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055Y9.
3. Willet CG, Badizadegan K, Ancukiewicz M, Shellito PC. Prognostic factors in stage T3N0. Do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 1999;42:167Y73.
4. Merchant NB, Guillem JG, Paty PB, et al. T3 N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 1999;3:642Y7.
5. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001;16:298Y304.
6. Steel MC, Woods R, Mackay JM, Chen F. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. Anz J Surg 2002;72:483Y7.
7. Miyoshi M, Ueno H, Hashiguchi Y, Mochizuki H, Talbot IC. Extent of mesorectal tumor invasion as a prognostic factor alters curative surgery for T3 rectal cancer patients. Ann Surg 2006;243:492Y7.
8. Eriksen MT, Wibe A, Haffner J, Wiig JN, on behalf of The Norwegian Rectal Cancer Group. Prognostic in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 2007;50:156Y67.
9. Kwok H, Bisset IP, Hill GL. Preoperative staging of rectal cancer. Int J Colorectal Dis 2000;15:9Y20.
10. Brown G. Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer. Br J Radiol 2005;78:S117Y27.
11. Brown G, Richards CJ, Newcombe RG, et al. Rectal carcinoma: thin-section MRImaging for staging in 28 patients. Radiology 1999;211:215Y22.
12. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003;90:355Y64.
13. Goh V, Halligan S, Bartram CI. Local radiological staging of rectal cancer. Clin Radiol 2004;9:215Y26.
14. Tjandra JJ, Kilkenny JW, Buie WD, et al. Standards Practice Task Force; The American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (Revised). Dis Colon Rectum 2005;48:411Y23.
15. Hildebrandt U, Feifel G. Preoperative staging of rectal cancer by intrarectal ultrasound. Dis Colon Rectum 1985;28:42Y6.
16. Schaffzin DM, Wong WD. Surgeon-performed ultrasound: endorectal ultrasound. Surg Clin N Am 2004;84:1127Y49.
17. Harewood G, Kumar KS, Clain JE, Levy MJ, Nelson H. Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: all T3 rectal cancer are not equal. J Gastroenterol Hepatol 2004;19:750Y55.
18. Hildebrandt U, Feifel G, Schwarz HP, Scherr O. Endorectal ultrasound: instrumentation and clinical aspects. Int J Colorectal Dis 1986;1:203Y7.
19. Beynon J,Mortensen NJ, Foy DM, Chaner JL, Rigby H, Virjee J. Preoperative assessment of mesorectal lymph node involvement in rectal cancer. Br J Surg 1989;76:276Y9.
20. Hildebrandt U. Preoperative staging: a critical analysis. In: Soreide O, Norstein J, eds. Rectal cancer surgery. Optimisation Y standardisation Y documentation. Berlin: Springer, 1997:82Y100.
21. Quirke P, Durdey P, Dixon Mf, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996Y9.
22. Nicholls RJ, Galloway DJ, Mason AY, Boyle P. Clinical local staging of rectal cancer. Br J Surg 1985;72:S51Y2.
23. Lee SH, Hernandez de Anda E, Finne CO, Madoff RD, Garcia- Aguilar J. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Dis Colon Rectum 2005;48:2249Y57.
24. Greene FL, Stewart AK, Norton J. New tumor-node-metastasis staging strategy for node positive (stage III) rectal cancer: an analysis. J Clin Oncol 2004;22:1778Y84.
25. SchaffzinDM,WongWD. Invited commentary. In: Santoro GA, Di Falco G, eds. Atlas of endoanal and endorectal ultrasonography. Staging and treatment options for anorectal cancer. Milan: Springer, 2004:95Y7.
26. Santoro GA, Di Falco G. Endoluminal ultrasound in the preoperative staging of rectal carcinoma. Introduction. In: Santoro GA, Di Falco G, eds. Atlas of endoanal and endorectal ultrasonography. Staging and treatment options for anorectal cancer. Milan: Springer, 2004:51Y60.
27. Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002;45:10Y5.
28. Herzog U, von Flue M, Tondelli P, Schuppisser JP. How accurate is endorectal ultrasound in the preoperative staging of rectal cancer? Dis Colon Rectum 1993;36:127Y34.
29. Kruskal JB, Kane RA, Sentovich SM, Longmaid HE. Pitfalls and sources of error in staging rectal cancer with endorectal US. Radiographics 1997;17:609Y26.
30. Hermanek P. Impact of surgeon's technique on the outcome after treatment of rectal cancer. Dis Colon Rectum 1999;42:559Y62.
31. Martling A, Cedemark B, Johansson H, Rutqvist LE, Holm T. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 2002;89:1008Y13.
32. Wibe A, Ericksen MT, Syse A, Tretli S, Myrvold HE, Soreide O, on behalf of the Norwegian Rectal Cancer Group. Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level. Br J Surg 2005;92:217Y24.
33. Garc
34. Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol 2003;4:695Y702.
35. Hermanek P, Hermanek P Jr, Hohenberger W, Klimpfinger, KPckerling F, Papadopoulus T. The pathological assessment of mesorectal excision. Implications for further treatment and quality management. Int J Colorectal Dis 2003;18:335Y41.
36. Birbeck K, Macklin C, Tiffin N, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449Y57.
37. Nagtegaal ID, Marijnen CA, Kranenbarg EK, Van de Velde CJ, Van Krieken JH. Circumferential margin involvements is still an important predictor of local recurrence in rectal carcinoma. Not one millimetre but two is the limit. Am J Surg Pathol 2002;26:350Y7.
38. Haas-Kock DF, Baeten CG, Jager JJ, et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 1996; 83:781Y5.
39. Wibe A, Rendedal PR, Svensson E, Norstein J, et al, On behalf of the Norwegian Rectal Cancer Group. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327Y34.